Comparison of 2 dosages of intraarticular triamcinolone for the treatment of knee arthritis: results of a 12-week randomized controlled clinical trial

J.W. Popma, Frank W. Snel, Cees J. Haagsma, Petra Brummelhuis-Visser, Hans G.J. Oldenhof, Jacobus Adrianus Maria van der Palen, Mart A F J van de Laar

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)


Objective. To determine whether a double dose of intraarticular triamcinolone acetonide is more effective for knee arthritis than a 40-mg dose. Methods. In this 12-week randomized controlled clinical trial, 40 mg and 80 mg of intraarticular triamcinolone acetonide were compared in patients with knee arthritis. Evaluated variables included a Likert burden scale, visual analog scale pain scale, degree of arthritis activity, presence of swelling, and presence of functional limitation. Results. Ninety-seven patients were randomized. No significant differences were observed between the groups regarding any outcomes. Conclusion. An 80-mg dose of triamcinolone acetonide had no additional benefit compared with 40 mg as treatment for knee arthritis.
Original languageEnglish
Pages (from-to)1865-1868
Number of pages4
JournalJournal of rheumatology
Issue number10
Publication statusPublished - 2015



  • METIS-311806
  • IR-97245

Cite this